AbbVie made a change atop its board of directors, naming CEO Robert Michael as chairman on Friday morning. The pharma giant announced that Michael will succeed Richard A. Gonzalez, the former CEO of ...
AbbVie named its chief executive, Robert Michael, to succeed Richard Gonzales as chairman of the biopharmaceutical company, effective July 1. AbbVie on Friday said Gonzalez, who has been chairman of ...
AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 ...
AbbVie (ABBV) announced that its board of directors has unanimously elected CEO Robert Michael to assume the additional position of chairman, ...
Company Announcement COPENHAGEN, Denmark; February 12, 2025 - Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2024. Below is a summary of business progress in 2024 ...
Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...
Report with market evolution powered by AI - The global antibiotics market size is estimated to grow by USD 18.22 billion ...
The first shot taken at Medicaid, likely UnitedHealthcare coverage for Vertex's pain drug, and Optum’s wellness visit ad.
The Dividend chart for Abbvie (ABBV) shows us the per share payout over time. Dividends are a distribution to shareholders, and they define how much money a company is roviding to its shareholders ...
Investopedia / Ryan Oakley The World Trade Organization (WTO) is an international institution that oversees the rules for global trade among nations. It was created in 1995, superseding the 1947 ...
Shares of AbbVie (NYSE: ABBV) were jumping 7.1% higher as of 11:10 a.m. ET on Friday after rising as much as 9.2% earlier in the day. The nice gain stemmed from the big drugmaker's 2024 fourth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results